Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Human Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Human Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Human Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Human Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Human Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Human Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Human Vaccine development has been the leading industry trend of Human Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Human Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Varicella,Influenza,Polio,Hepatitis A,Rabies,BCG,Hepatitis B,Other |
| By Application Outlook |
Adults,Children, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
CNBG,Changsheng Life,Zhifei,ChengDa Bio,Kangtai,SINOVAC BIOTECH,Hissen,Walvax Biotechnology,GSK,SANOFI,Rong An,NuoCheng Bio,Hualan Bio,Tiantan biological,Changchun Baike,Adimmune,Zhongyianke Biotech |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- CNBG
- Changsheng Life
- Zhifei
- ChengDa Bio
- Kangtai
- SINOVAC BIOTECH
- Hissen
- Walvax Biotechnology
- GSK
- SANOFI
- Rong An
- NuoCheng Bio
- Hualan Bio
- Tiantan biological
- Changchun Baike
- Adimmune
- Zhongyianke Biotech
Human Vaccine Market, By Type
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Other
Human Vaccine Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Human Vaccine Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Human Vaccine Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Human Vaccine Industry Overview
2.1 Global Human Vaccine Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Human Vaccine Global Import Market Analysis
2.1.2 Human Vaccine Global Export Market Analysis
2.1.3 Human Vaccine Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Other
2.3.2 Children
2.4.2 Global Human Vaccine Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Human Vaccine Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Human Vaccine Manufacturer Market Share
2.4.5 Top 10 Human Vaccine Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Human Vaccine Market
2.4.7 Key Manufacturers Human Vaccine Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Human Vaccine Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Human Vaccine Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Human Vaccine Market Size Categorized by Regions
4.1 Global Human Vaccine Revenue, Sales and Market Share by Regions
4.1.1 Global Human Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 Europe Human Vaccine Sales and Growth Rate (2015-2020)
4.3 APAC Human Vaccine Sales and Growth Rate (2015-2020)
4.4 North America Human Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Human Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Vaccine Sales and Growth Rate (2015-2020)
5 Europe Human Vaccine Market Size Categorized by Countries
5.1 Europe Human Vaccine Sales, Revenue and Market Share by Countries
5.1.1 Europe Human Vaccine Sales by Countries (2015-2020)
5.1.2 Europe Human Vaccine Revenue by Countries (2015-2020)
5.1.3 Germany Human Vaccine Sales and Growth Rate (2015-2020)
5.1.4 UK Human Vaccine Sales and Growth Rate (2015-2020)
5.1.5 France Human Vaccine Sales and Growth Rate (2015-2020)
5.1.6 Russia Human Vaccine Sales and Growth Rate (2015-2020)
5.1.7 Italy Human Vaccine Sales and Growth Rate (2015-2020)
5.1.8 Spain Human Vaccine Sales and Growth Rate (2015-2020)
5.2 Europe Human Vaccine Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Human Vaccine Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Human Vaccine Sales Market Share by Type (2015-2020)
5.3.2 Europe Human Vaccine Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Human Vaccine Sales Market Share by Application (2015-2020)
6 Asia-Pacific Human Vaccine Market Size Categorized by Countries
6.1 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Human Vaccine Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Human Vaccine Revenue by Countries (2015-2020)
6.1.3 China Human Vaccine Sales and Growth Rate (2015-2020)
6.1.4 Japan Human Vaccine Sales and Growth Rate (2015-2020)
6.1.5 Korea Human Vaccine Sales and Growth Rate (2015-2020)
6.1.6 India Human Vaccine Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Human Vaccine Sales and Growth Rate (2015-2020)
6.1.8 Australia Human Vaccine Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Human Vaccine Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Human Vaccine Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Human Vaccine Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Human Vaccine Sales and Market Share by Application (2015-2020)
7 North America Human Vaccine Market Size Categorized by Countries
7.1 North America Human Vaccine Sales, Revenue and Market Share by Countries
7.1.1 North America Human Vaccine Sales by Countries (2015-2020)
7.1.2 North America Human Vaccine Revenue by Countries (2015-2020)
7.1.3 United States Human Vaccine Sales and Growth Rate (2015-2020)
7.1.4 Canada Human Vaccine Sales and Growth Rate (2015-2020)
7.1.5 Mexico Human Vaccine Sales and Growth Rate (2015-2020)
7.2 North America Human Vaccine Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Human Vaccine Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Human Vaccine Sales Market Share by Type (2015-2020)
7.3.2 North America Human Vaccine Revenue and Revenue Share by Type (2015-2020)
7.4 North America Human Vaccine Sales Market Share by Application (2015-2020)
8 South America Human Vaccine Market Size Categorized by Countries
8.1 South America Human Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Human Vaccine Sales by Countries (2015-2020)
8.1.2 South America Human Vaccine Revenue by Countries (2015-2020)
8.1.3 Brazil Human Vaccine Sales and Growth Rate (2015-2020)
8.2 South America Human Vaccine Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Human Vaccine Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Human Vaccine Sales Market Share by Type (2015-2020)
8.3.2 South America Human Vaccine Revenue and Revenue Share by Type (2015-2020)
8.4 South America Human Vaccine Sales Market Share by Application (2015-2020)
9 Middle East and Africa Human Vaccine Market Size Categorized by Countries
9.1 Middle East and Africa Human Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Vaccine Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Human Vaccine Revenue by Countries (2015-2020)
9.1.3 GCC Countries Human Vaccine Sales and Growth Rate (2015-2020)
9.1.4 Turkey Human Vaccine Sales and Growth Rate (2015-2020)
9.1.5 Egypt Human Vaccine Sales and Growth Rate (2015-2020)
9.1.6 South Africa Human Vaccine Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Human Vaccine Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Human Vaccine Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Human Vaccine Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Human Vaccine Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Human Vaccine Sales Market Share by Application (2015-2020)
10 Global Human Vaccine Market Segment by Type
10.1 Global Human Vaccine Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Human Vaccine Sales and Market Share by Type (2015-2020)
10.1.2 Global Human Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Varicella Sales Growth Rate and Price
10.2.1 Global Varicella Sales Growth Rate (2015-2020)
10.2.2 Global Varicella Price (2015-2020)
10.3 Influenza Sales Growth Rate and Price
10.3.1 Global Influenza Sales Growth Rate (2015-2020)
10.3.2 Global Influenza Price (2015-2020)
10.4 Polio Sales Growth Rate and Price
10.4.1 Global Polio Sales Growth Rate (2015-2020)
10.4.2 Global Polio Price (2015-2020)
10.5 Hepatitis A Sales Growth Rate and Price
10.5.1 Global Hepatitis A Sales Growth Rate (2015-2020)
10.5.2 Global Hepatitis A Price (2015-2020)
10.6 Rabies Sales Growth Rate and Price
10.6.1 Global Rabies Sales Growth Rate (2015-2020)
10.6.2 Global Rabies Price (2015-2020)
10.7 BCG Sales Growth Rate and Price
10.7.1 Global BCG Sales Growth Rate (2015-2020)
10.7.2 Global BCG Price (2015-2020)
10.8 Hepatitis B Sales Growth Rate and Price
10.8.1 Global Hepatitis B Sales Growth Rate (2015-2020)
10.8.2 Global Hepatitis B Price (2015-2020)
10.9 Other Sales Growth Rate and Price
10.9.1 Global Other Sales Growth Rate (2015-2020)
10.9.2 Global Other Price (2015-2020)
11.1 Global Human VaccineSales Market Share by Application (2015-2020)
11.2 Adults Sales Growth Rate (2015-2020)
11.3 Children Sales Growth Rate (2015-2020)
12.1 Global Human Vaccine Revenue, Sales and Growth Rate (2020-2027)
12.2 Human Vaccine Market Forecast by Regions (2020-2027)
12.2.1 Europe Human Vaccine Market Forecast (2020-2027)
12.2.2 APAC Human Vaccine Market Forecast (2020-2027)
12.2.3 North America Human Vaccine Market Forecast (2020-2027)
12.2.4 South America Human Vaccine Market Forecast (2020-2027)
12.2.5 Middle East & Africa Human Vaccine Market Forecast (2020-2027)
12.3 Human Vaccine Market Forecast by Type (2020-2027)
12.3.1 Global Human Vaccine Sales Forecast by Type (2020-2027)
12.3.2 Global Human Vaccine Market Share Forecast by Type (2020-2027)
12.4 Human Vaccine Market Forecast by Application (2020-2027)
12.4.1 Global Human Vaccine Sales Forecast by Application (2020-2027)
12.4.2 Global Human Vaccine Market Share Forecast by Application (2020-2027)
13 Analysis of Human Vaccine Industry Key Manufacturers
13.1 CNBG
13.1.1 Company Details
13.1.2 Product Information
13.1.3 CNBG Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 CNBG News
13.2 Changsheng Life
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Changsheng Life Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Changsheng Life News
13.3 Zhifei
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Zhifei Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Zhifei News
13.4 ChengDa Bio
13.4.1 Company Details
13.4.2 Product Information
13.4.3 ChengDa Bio Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 ChengDa Bio News
13.5 Kangtai
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Kangtai Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Kangtai News
13.6 SINOVAC BIOTECH
13.6.1 Company Details
13.6.2 Product Information
13.6.3 SINOVAC BIOTECH Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 SINOVAC BIOTECH News
13.7 Hissen
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Hissen Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Hissen News
13.8 Walvax Biotechnology
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Walvax Biotechnology Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Walvax Biotechnology News
13.9 GSK
13.9.1 Company Details
13.9.2 Product Information
13.9.3 GSK Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 GSK News
13.10 SANOFI
13.10.1 Company Details
13.10.2 Product Information
13.10.3 SANOFI Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 SANOFI News
13.11 Rong An
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Rong An Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Rong An News
13.12 NuoCheng Bio
13.12.1 Company Details
13.12.2 Product Information
13.12.3 NuoCheng Bio Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 NuoCheng Bio News
13.13 Hualan Bio
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Hualan Bio Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Hualan Bio News
13.14 Tiantan biological
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Tiantan biological Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Tiantan biological News
13.15 Changchun Baike
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Changchun Baike Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Changchun Baike News
13.16 Adimmune
13.16.1 Company Details
13.16.2 Product Information
13.16.3 Adimmune Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.16.4 Main Business Overview
13.16.5 Adimmune News
13.17 Zhongyianke Biotech
13.17.1 Company Details
13.17.2 Product Information
13.17.3 Zhongyianke Biotech Human Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.17.4 Main Business Overview
13.17.5 Zhongyianke Biotech News
15 Appendix